Life Sciences

The global pharmaceutical company has received U.S. Food and Drug Administration approval for commercial cell therapy manufacturing in Devens.

Marlborough firm Akoya Biosciences has eliminated two C-suite positions as part of an initiative to cut its expenses, as it aims to raise $43.5 million in additional funding.

Gov. Maura Healey plans to continue a high-dollar commitment to the life sciences sector that began under former Gov. Deval Patrick, and her administration is also launching a new platform to recruit diverse hires to the sector and provide training opportunities.

Attracting and diversifying a robust talent pool is a primary concern in keeping up with the growth of the life science industry in Massachusetts, according to the 2023 Massachusetts Life Sciences Employment Outlook report.

Five life science companies with significant operations in Central Mass. were among the 43 firms across Massachusetts chosen to split $24.4 million in tax incentive awards.

Gov. Maura Healey and the Massachusetts Life Sciences Center announced $24.4 million in tax incentive awards Tuesday that they expect will help 43 life sciences companies create nearly 1,600 new jobs, and officials teased more "exciting" life sciences news around the corner as the BIO International Convention lands in Boston next week.

RP Masiello broke ground on a new biopharma manufacturing facility on Commerce Drive in Northbridge on Wednesday. The 40,000-square-foot project is expected to be completed in late 2024.

People are on the move at ERA Key Realty, Cunningham Equities, and more Central Massachusetts businesses.

Marlborough medical device manufacturer Hologic has received U.S. Food and Drug Administration clearance for a new combined test that can detect influenza A and B, respiratory syncytial virus (RSV) and coronavirus.

Jean King, the dean of school of arts and sciences at Worcester Polytechnic Institute, has been named to a top council at the National Institutes of Health.